LC separation of calcipotriol from its photodegradation products and protection possibilities using adjuvants.

Mobile phase optimization and reversed-phase column characteristics were used to separate photodegradation products from the parent compound, 24-cyclopropyl-9-,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol (calcipotriol). Separation between calcipotriol and its degradation products was obtained with an acetonitrile/water (53:47, v/v) mobile phase on a C(18) Hypersil ODS column (250 mm length, 4.6 mm id, 5 microm particle size) and a flow rate of 1 ml/min. Using this system, the influence of commonly used solvents in dermatology on degradation was studied. The addition of a UV filter in two concentrations was also evaluated for its possible protective effect to light exposure. Propylene glycol and polyethylene glycol 400 decreased the speed of degradation. The sunscreen 2-hydroxy-4-methoxybenzophenone affords a protection proportional to the filter concentration used in the study.

Separation from related compounds and assay of calcipotriol by high-performance liquid chromatography.

In this paper, two methods are presented. One involves the separation of calcipotriol, a new synthetic analogue, from two related compounds, specifically cholecalciferol (Vitamin D3) and calcitriol (1,25-dihydroxyvitamin D3). The other involves the isolation and assay of calcipotriol from a topical ointment. The study was performed with reversed-phase high-performance liquid chromatography using an RP18 column and ultraviolet detection. Applying the method of Snyder, a mobile phase mixture containing methanol-acetonitrile-water (67:23:10, v/v) was found which achieved a total separation within 18 min. A mobile phase of methanol-water (80:20, v/v) attained a slower elution of calcipotriol. For isolation and assay of calcipotriol from an ointment (Daivonex), dissolution in chloroform gave the highest recovery (> 98%). The isolation and assay process can be performed within 2 h.